Home/Filings/4/0001828185-25-000009
4//SEC Filing

Hooftman Leon 4

Accession 0001828185-25-000009

CIK 0001828185other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:24 PM ET

Size

5.9 KB

Accession

0001828185-25-000009

Insider Transaction Report

Form 4
Period: 2025-02-03
Hooftman Leon
Chief Medical Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2025-02-03+140,000140,000 total
    Exercise: $1.00Exp: 2035-02-03Ordinary Shares (140,000 underlying)
Footnotes (2)
  • [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Barinthus Biotherapeutics plc.

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0002027157

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:24 PM ET
Size
5.9 KB